Genome Editing & Genome Engineering Market
Genome Editing & Genome Engineering Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Genome Editing & Genome Engineering Market Size and Growth
The Genome Editing & Genome Engineering market is witnessing robust growth, driven by technological advancements and increasing applications in healthcare and agriculture. As of 2023, the market size is projected to reach approximately $9 billion, with a CAGR exceeding 15%, reflecting significant investment and innovation in genetic technologies.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Merck
◍ Horizon Discovery
◍ Genscript
◍ Sangamo Biosciences
◍ Integrated Dna Technologies
◍ Lonza
◍ New England Biolabs
◍ Origene Technologies
◍ Transposagen Biopharmaceuticals
◍ Editas Medicine
◍ Crispr Therapeutics
The Genome Editing & Engineering Market is competitive, with key players including Thermo Fisher Scientific, Merck, and CRISPR Therapeutics. These companies provide advanced tools for genetic modifications, enhancing research and therapeutic applications. They contribute to market growth through innovative products, collaborations, and expanding service portfolios.
Sales revenue (latest figures):
- Thermo Fisher Scientific: ~$40 billion
- Merck: ~$57 billion
- New England Biolabs: ~$1 billion
- Editas Medicine: ~$40 million.
Request Sample Report
Market Segmentation
By Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
